Hey friends! We’re thrilled to share some exciting news about a new clinical study we’re conducting with a contraceptive device called NuvaRing, specifically for ovum donors. Traditionally, we’ve relied on birth control pills for our donors in the lead-up to their IVF procedures. Why? Well, it helps ensure that the donor doesn’t get pregnant just before starting Lupron, which is crucial for the IVF process. Plus, these hormonal pills typically prevent ovulation, minimizing the risk of cysts when the donor begins her treatment.
However, taking a pill every day for 14 to 35 days can be a hassle. Enter NuvaRing, a soft silastic ring containing estrogen and progesterone analogs that the donor places in her vagina for 21 days. The beauty of this device is that it eliminates the daily pill reminder, making it easier to stick to the regimen. We’ll be gauging the experience through questionnaires to see how the donors like the ring and if they’d consider it for future birth control.
In this randomized clinical trial, 30 donors will participate—15 using the NuvaRing and 15 continuing with the traditional birth control pills. The best part? Organon is providing the rings and pills at no cost to the participants. If you’re curious about the flexibility of the ring, check out this interactive example.
As we dive into this study, it’s also a great time to reflect on the balance in our lives. For some guidance, take a look at our blog post on mindful balance by Jessica Lane here. And if you’re exploring options for home insemination, Make a Mom is a fantastic resource.
In summary, we’re excited about the potential of NuvaRing for ovum donors, as it could simplify their experience leading up to IVF. Stay tuned for updates on this groundbreaking study!